Publication | Closed Access

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

Type 1Cardiovascular DiseaseMicrovascular DysfunctionDiabetesDiabetes ComplicationsHyperglycemiaDiabetes MellitusMicrovascular ComplicationsMedicineAtherosclerosisSerum Levels